These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12099369)

  • 1. Allorecognition.
    Rogers NJ; Lechler RI
    Am J Transplant; 2001 Jul; 1(2):97-102. PubMed ID: 12099369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allorecognition.
    Côté I; Rogers NJ; Lechler RI
    Transfus Clin Biol; 2001 Jun; 8(3):318-23. PubMed ID: 11499986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathways of allorecognition: implications for transplantation tolerance.
    Game DS; Lechler RI
    Transpl Immunol; 2002 Aug; 10(2-3):101-8. PubMed ID: 12216939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct and indirect antigen recognition: the pathways to allograft immune rejection.
    Benichou G
    Front Biosci; 1999 May; 4():D476-80. PubMed ID: 10331992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance.
    Jiang S; Herrera O; Lechler RI
    Curr Opin Immunol; 2004 Oct; 16(5):550-7. PubMed ID: 15341998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans.
    Hornick PI; Mason PD; Yacoub MH; Rose ML; Batchelor R; Lechler RI
    Circulation; 1998 Apr; 97(13):1257-63. PubMed ID: 9570195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of the indirect pathway of allorecognition in clinical transplantation.
    Gökmen MR; Lombardi G; Lechler RI
    Curr Opin Immunol; 2008 Oct; 20(5):568-74. PubMed ID: 18655831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathways of major histocompatibility complex allorecognition.
    Afzali B; Lombardi G; Lechler RI
    Curr Opin Organ Transplant; 2008 Aug; 13(4):438-44. PubMed ID: 18685342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indirect T cell recognition in allograft rejection.
    Bradley JA
    Int Rev Immunol; 1996; 13(3):245-55. PubMed ID: 8782745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of alloreactivity to MHC-derived peptides and transplantation tolerance.
    Benichou G; Kant CD; Madsen J; Tocco G
    Front Biosci; 2007 May; 12():4239-47. PubMed ID: 17485370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct and indirect cross-tolerance of alloreactive T cells by dendritic cells retained in the immature stage.
    Nouri-Shirazi M; Guinet E
    Transplantation; 2002 Oct; 74(7):1035-44. PubMed ID: 12394851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition.
    Khan A; Fu H; Tan LA; Harper JE; Beutelspacher SC; Larkin DF; Lombardi G; McClure MO; George AJ
    Eur J Immunol; 2013 Mar; 43(3):734-46. PubMed ID: 23212959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of two distinct alloresponse pathways on the design of peptide-based strategies for allograft tolerance.
    Benichou G; Tam RC; Soares LR; Popov IA; Garovoy MR; Fedoseyeva EV
    Res Immunol; 1996; 147(6):377-87. PubMed ID: 8903104
    [No Abstract]   [Full Text] [Related]  

  • 14. CD8 T-cell recognition of acquired alloantigen promotes acute allograft rejection.
    Harper SJ; Ali JM; Wlodek E; Negus MC; Harper IG; Chhabra M; Qureshi MS; Mallik M; Bolton E; Bradley JA; Pettigrew GJ
    Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12788-93. PubMed ID: 26420874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic graft loss. Immunological and non-immunological factors.
    Hernandez-Fuentes MP; Lechler RI
    Contrib Nephrol; 2005; 146():54-64. PubMed ID: 15567920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of autoimmunity after skin graft rejection via an indirect alloresponse.
    Valujskikh A; Fedoseyeva E; Benichou G; Heeger PS
    Transplantation; 2002 Apr; 73(7):1130-7. PubMed ID: 11965045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New strategies for early diagnosis of heart allograft rejection.
    Tugulea S; Ciubotariu R; Colovai AI; Liu Z; Itescu S; Schulman LL; Fisher PE; Hardy MA; Rose EA; Michler RE; Cortesini R; Suciu-Foca N
    Transplantation; 1997 Sep; 64(6):842-7. PubMed ID: 9326408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alloresponse.
    Hernandez-Fuentes MP; Baker RJ; Lechler RI
    Rev Immunogenet; 1999; 1(3):282-96. PubMed ID: 11256420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerogenic response: allorecognition pathways.
    Caballero A; Fernandez N; Lavado R; Bravo MJ; Miranda JM; Alonso A
    Transpl Immunol; 2006 Dec; 17(1):3-6. PubMed ID: 17157204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect T-cell allorecognition: perspectives for peptide-based therapy in transplantation.
    Benichou G; Tam RC; Soares LR; Fedoseyeva EV
    Immunol Today; 1997 Feb; 18(2):67-71. PubMed ID: 9057356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.